Enterococcal Bacteremia
Learn about Enterococcal Bacteremia (Enterococcus Bacteremia), a bloodstream infection caused by Enterococcus bacteria. This resource provides information on diagnosis, clinical documentation, and medical coding for Enterococcal Bloodstream Infection, essential for healthcare professionals. Find details on symptoms, treatment, and ICD codes related to Enterococcal Bacteremia for accurate and efficient healthcare management.
Bloodstream infection caused by Enterococcus bacteria.
Fever, chills, rapid heart rate, low blood pressure, sometimes no symptoms.
Healthcare-associated infections, UTI complications, weakened immune system.
ICD-10 Code Families
Complete code families applicable to A41.81
When to use each related code
| Description | When to use |
|---|---|
| Enterococcus in the bloodstream. | Use when a blood culture confirms Enterococcus species infection. Consider source. |
| Staphylococcus in the bloodstream. | Use when a blood culture confirms Staphylococcus species infection. Specify coagulase status if known. |
| Streptococcus in the bloodstream. | Use when a blood culture confirms Streptococcus species infection. Specify species if known. |
Best-practice checklist
- ✓Document positive blood culture identifying Enterococcus species.
- ✓Specify Enterococcus species (e.g., E. faecalis, E. faecium).
- ✓Document source of infection if identified (e.g., UTI, wound).
- ✓Record patient's signs and symptoms (e.g., fever, chills).
- ✓Document antibiotic treatment and response to therapy.
Common pitfalls to avoid
Confusing enterococcal bacteremia with sepsis or severe sepsis can lead to inaccurate coding and DRG assignment.
Failing to specify the Enterococcus species (e.g., faecalis, faecium) may impact reimbursement and antimicrobial stewardship.
Incorrect POA assignment can affect hospital-acquired infection reporting and quality measures.
Best-practice tips
- 01Timely blood cultures, appropriate antibiotics per guidelines
- 02Source control: Remove catheters, drain abscesses promptly
- 03Optimal hand hygiene, aseptic technique for all procedures
- 04Document infection signs, antibiotic choice, source control efforts
- 05Monitor patient response to therapy, adjust treatment as needed
Step-by-step checklist
- 1
Confirm positive blood culture for Enterococcus species (ICD-10 A41.81)
- 2
Document source of infection (e.g., urinary, intra-abdominal)
- 3
Assess patient risk factors: age, comorbidities, indwelling devices
- 4
Evaluate antimicrobial susceptibility for targeted therapy (e.g., ampicillin, vancomycin)
Ready-to-paste narrative
Patient presents with signs and symptoms suggestive of enterococcal bacteremia, including fever, chills, rigors, and malaise. The patient may also exhibit tachycardia, hypotension, and altered mental status. Risk factors for enterococcal bloodstream infection include indwelling urinary catheters, intravascular devices, recent gastrointestinal or genitourinary procedures, immunosuppression, and underlying comorbidities such as diabetes mellitus. Blood cultures were drawn and preliminary results indicate gram-positive cocci in clusters, raising suspicion for Enterococcus species. Differential diagnosis includes other causes of bacteremia, sepsis, and systemic inflammatory response syndrome (SIRS). Laboratory tests including complete blood count (CBC) with differential, comprehensive metabolic panel (CMP), and inflammatory markers such as procalcitonin and C-reactive protein (CRP) have been ordered to assess the severity of illness and monitor response to therapy. Empiric antibiotic therapy has been initiated with vancomycin pending species identification and susceptibility testing. Further investigations will focus on identifying the source of infection and evaluating for potential complications such as endocarditis, intra-abdominal abscess, or urinary tract infection. The patient's clinical status will be closely monitored, and antibiotic therapy will be adjusted based on culture results and clinical response. Infection control precautions have been implemented as per hospital protocol. Continued assessment for signs of septic shock and multi-organ dysfunction syndrome (MODS) is warranted. Patient education regarding infection prevention and appropriate antibiotic use will be provided. The case will be discussed with the infectious disease consult service for recommendations on optimal antibiotic duration and management.
Common questions and answers
What are the recommended empiric antibiotic treatment options for suspected Enterococcal Bacteremia in adults, considering vancomycin resistance?+
Empiric antibiotic treatment for suspected Enterococcal Bacteremia in adults should consider the possibility of vancomycin resistance. For patients with severe infections or risk factors for vancomycin-resistant enterococci (VRE), such as recent hospitalization, prolonged antibiotic use, or known VRE colonization, initial therapy should include an agent active against VRE. Options include daptomycin, linezolid, or quinupristin-dalfopristin. If vancomycin susceptibility is confirmed, it remains a viable option. For patients without risk factors for VRE, ampicillin-sulbactam or vancomycin can be used empirically. Ultimately, antibiotic choice should be guided by local resistance patterns and patient-specific factors like renal function and allergies. Explore how our antibiogram tool can help personalize treatment decisions based on your institution's data. Consider implementing routine VRE screening for high-risk patients to optimize empiric therapy selection.
How do I differentiate Enterococcal Bacteremia from contamination in blood cultures, and what are the key clinical indicators to consider?+
Differentiating true Enterococcal Bacteremia from blood culture contamination requires careful evaluation of clinical context and laboratory findings. True bacteremia is often associated with signs and symptoms of infection, such as fever, chills, hypotension, or end-organ dysfunction. Multiple positive blood cultures, particularly from separate venipuncture sites, strengthen the likelihood of true infection. The presence of an intravascular catheter increases the risk of contamination; however, even catheter-related bloodstream infections can be caused by Enterococci. Conversely, a single positive blood culture with a common skin commensal like Enterococcus faecalis in a clinically stable patient without other signs of infection suggests contamination. Reviewing the patient's medical history, including recent procedures, underlying diseases, and antibiotic exposure, can further aid in distinguishing contamination from true bacteremia. Learn more about the latest guidelines on blood culture interpretation and management of bloodstream infections.
What is the recommended duration of antibiotic therapy for Enterococcal Bacteremia, and how should I monitor treatment response?+
The recommended duration of antibiotic therapy for Enterococcal Bacteremia varies depending on the source and severity of infection, as well as the presence of complications such as endocarditis or osteomyelitis. For uncomplicated Enterococcal Bacteremia without a clear source, a treatment duration of 2-4 weeks is generally recommended after the patient becomes afebrile and blood cultures clear. However, infections involving intravascular devices often require removal of the device and a shorter course of therapy (e.g., 1-2 weeks after device removal). For complicated infections like endocarditis or osteomyelitis, significantly longer courses of therapy (4-6 weeks or more) are often necessary. Monitoring treatment response involves serial blood cultures to document clearance of bacteremia, as well as clinical assessment of symptoms and signs of infection. Consider implementing a standardized protocol for managing Enterococcal Bacteremia to ensure appropriate treatment duration and monitoring. Explore how our clinical decision support tools can assist in personalizing antibiotic stewardship strategies.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.